Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity
Xavier Nadal, Eduardo Muñóz(Instituto Maimónides de Investigación Biomédica de Córdoba)
Cited by 125
Related Papers
Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1
|Redox Biology|2019|167
The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways
|Scientific Reports|2016|91
VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease
|Scientific Reports|2016|78
Betulinic acid hydroxamate prevents colonic inflammation and fibrosis in murine models of inflammatory bowel disease
|Acta Pharmacologica Sinica|2020|48
Tetrahydrocannabinolic acid A (THCA-A) reduces adiposity and prevents metabolic disease caused by diet-induced obesity
|Biochemical Pharmacology|2019|43